Molbio Diagnostics is thrilled to announce a momentous collaboration with ShanMukha Innovations to commercialize India's first point-of-care confirmatory test for Sickle Cell Disease (SCD) and engage in joint development of new products. This remarkable achievement marks a significant milestone in our mission to provide accessible and high-quality diagnostics for individuals across the country.
To expand rapid, onsite COVID-19 confirmatory testing for symptomatic people who test
negative to rapid antigen tests, and facilitate tuberculosis screening of people with COVID-19
symptoms, FIND and IHF are deploying five Truenat™ machines at select MCGM-run hospitals
in Mumbai
As the COVID-19 pandemic is expanding, there is a global shortfall of diagnostic supplies. It is critical for countries to strengthen indigenous production of diagnostic material to ensure uninterrupted availability
Read more